Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29333 | 188 | 19.8 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1214 | 2 | FACTOR XIII//TRANSGLUTAMINASE//TRANSGLUTAMINASE 2 | 9158 |
29333 | 1 | ANTISTREPTOKINASE ANTIBODY//STREPTOKINASE//STREPTOKINASE ANTIBODIES | 188 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTISTREPTOKINASE ANTIBODY | authKW | 974536 | 3% | 100% | 6 |
2 | STREPTOKINASE | authKW | 460349 | 22% | 7% | 41 |
3 | STREPTOKINASE ANTIBODIES | authKW | 324845 | 1% | 100% | 2 |
4 | STREPTOKINASE RESISTANCE | authKW | 324845 | 1% | 100% | 2 |
5 | ALLERGIC COMPLICATIONS | authKW | 162423 | 1% | 100% | 1 |
6 | ALTEPLASE R TPA | authKW | 162423 | 1% | 100% | 1 |
7 | ANTI SK ANTIBODIES | authKW | 162423 | 1% | 100% | 1 |
8 | ANTIGEN ANTIBODY EQUIVALENCE | authKW | 162423 | 1% | 100% | 1 |
9 | CELLULOSE BOUND PEPTIDE SCANS | authKW | 162423 | 1% | 100% | 1 |
10 | CLIN PHARMACOKINET CLIN PROGRAM | address | 162423 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 859 | 27% | 0% | 51 |
2 | Medicine, General & Internal | 306 | 20% | 0% | 37 |
3 | Allergy | 108 | 4% | 0% | 7 |
4 | Immunology | 102 | 13% | 0% | 24 |
5 | Peripheral Vascular Diseases | 100 | 7% | 0% | 14 |
6 | Hematology | 91 | 7% | 0% | 14 |
7 | Emergency Medicine | 65 | 3% | 0% | 5 |
8 | Medical Laboratory Technology | 24 | 2% | 0% | 4 |
9 | Medicine, Research & Experimental | 17 | 5% | 0% | 9 |
10 | Critical Care Medicine | 16 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOKINET CLIN PROGRAM | 162423 | 1% | 100% | 1 |
2 | CLIN STUDIES COMM | 162423 | 1% | 100% | 1 |
3 | HLTH INTERVENT TECHNOL | 162423 | 1% | 100% | 1 |
4 | HUMANITIES HLTH POLICY COMMUNITY EMPOWERMEN | 162423 | 1% | 100% | 1 |
5 | EUROPEAN ASSOC UROL | 54140 | 1% | 33% | 1 |
6 | CARDIAC GR H | 40604 | 1% | 25% | 1 |
7 | MECHANISM HUMAN TOX | 32483 | 1% | 20% | 1 |
8 | PL HLTH TECHNOL CLIN EPIDEMIOL | 32483 | 1% | 20% | 1 |
9 | SECT SMALL ANIM SURG NEUROL | 27069 | 1% | 17% | 1 |
10 | IMMUNOTECHNOL DIAGNOST | 16240 | 1% | 10% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH HEART JOURNAL | 6120 | 6% | 0% | 11 |
2 | FIBRINOLYSIS & PROTEOLYSIS | 5936 | 2% | 1% | 3 |
3 | AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1651 | 3% | 0% | 5 |
4 | MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE | 1287 | 1% | 1% | 1 |
5 | DICP-THE ANNALS OF PHARMACOTHERAPY | 1285 | 1% | 0% | 2 |
6 | INTERNATIONAL JOURNAL OF CARDIOLOGY | 664 | 4% | 0% | 7 |
7 | CLINICAL IMMUNOTHERAPEUTICS | 645 | 1% | 0% | 1 |
8 | VOPROSY VIRUSOLOGII | 645 | 2% | 0% | 3 |
9 | REVISTA ESPANOLA DE CARDIOLOGIA | 614 | 2% | 0% | 3 |
10 | LYON MEDICAL | 593 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTISTREPTOKINASE ANTIBODY | 974536 | 3% | 100% | 6 | Search ANTISTREPTOKINASE+ANTIBODY | Search ANTISTREPTOKINASE+ANTIBODY |
2 | STREPTOKINASE | 460349 | 22% | 7% | 41 | Search STREPTOKINASE | Search STREPTOKINASE |
3 | STREPTOKINASE ANTIBODIES | 324845 | 1% | 100% | 2 | Search STREPTOKINASE+ANTIBODIES | Search STREPTOKINASE+ANTIBODIES |
4 | STREPTOKINASE RESISTANCE | 324845 | 1% | 100% | 2 | Search STREPTOKINASE+RESISTANCE | Search STREPTOKINASE+RESISTANCE |
5 | ALLERGIC COMPLICATIONS | 162423 | 1% | 100% | 1 | Search ALLERGIC+COMPLICATIONS | Search ALLERGIC+COMPLICATIONS |
6 | ALTEPLASE R TPA | 162423 | 1% | 100% | 1 | Search ALTEPLASE+R+TPA | Search ALTEPLASE+R+TPA |
7 | ANTI SK ANTIBODIES | 162423 | 1% | 100% | 1 | Search ANTI+SK+ANTIBODIES | Search ANTI+SK+ANTIBODIES |
8 | ANTIGEN ANTIBODY EQUIVALENCE | 162423 | 1% | 100% | 1 | Search ANTIGEN+ANTIBODY+EQUIVALENCE | Search ANTIGEN+ANTIBODY+EQUIVALENCE |
9 | CELLULOSE BOUND PEPTIDE SCANS | 162423 | 1% | 100% | 1 | Search CELLULOSE+BOUND+PEPTIDE+SCANS | Search CELLULOSE+BOUND+PEPTIDE+SCANS |
10 | CLOT DIGEST | 162423 | 1% | 100% | 1 | Search CLOT+DIGEST | Search CLOT+DIGEST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BANDEHPOUR, M , SHARIFNIA, Z , MOHAJERI, N , TAHERKHANI, M , KOOCHAKI, A , YARIAN, F , SEYYED, N , SHIRVANI, R , PAKZAD, P , SAADAT, H , ET AL (2012) COMPARATIVE STUDY OF THE REACTIVITY OF NATURAL AND MUTATED STREPTOKINASE WITH TOTAL ANTISTREPTOKINASE ANTIBODIES IN HUMAN SERA.BLOOD COAGULATION & FIBRINOLYSIS. VOL. 23. ISSUE 8. P. 734-738 | 21 | 57% | 0 |
2 | SQUIRE, IB , LAWLEY, W , FLETCHER, S , HOLME, E , HILLIS, WS , HEWITT, C , WOODS, KL , (1999) HUMORAL AND CELLULAR IMMUNE RESPONSES UP TO 7 CENTER DOT 5 YEARS AFTER ADMINISTRATION OF STREPTOKINASE FOR ACUTE MYOCARDIAL INFARCTION.EUROPEAN HEART JOURNAL. VOL. 20. ISSUE 17. P. 1245 -1252 | 17 | 74% | 22 |
3 | TORRENS, I , OJALVO, AG , SERALENA, A , HAYES, O , DE LA FUENTE, J , (1999) A MUTANT STREPTOKINASE LACKING THE C-TERMINAL 42 AMINO ACIDS IS LESS IMMUNOGENIC.IMMUNOLOGY LETTERS. VOL. 70. ISSUE 3. P. 213 -218 | 17 | 74% | 8 |
4 | MCREDMOND, JP , MULVIHILL, NT , KANE, M , BURKE, B , ALOUL, B , FORDE, T , WALSH, M , FITZGERALD, DJ , (2004) A RAPID AGGLUTINATION ASSAY TO DETECT ANTI-STREPTOKINASE ANTIBODIES.IRISH JOURNAL OF MEDICAL SCIENCE. VOL. 173. ISSUE 4. P. 204-210 | 16 | 67% | 1 |
5 | LAISAAR, T , PULLERITS, T , (2003) EFFECT OF INTRAPLEURAL STREPTOKINASE ADMINISTRATION ON ANTISTREPTOKINASE ANTIBODY LEVEL IN PATIENTS WITH LOCULATED PLEURAL EFFUSIONS.CHEST. VOL. 123. ISSUE 2. P. 432-435 | 13 | 81% | 7 |
6 | URDAHL, KB , MATHEWS, JD , CURRIE, B , (1996) ANTI-STREPTOKINASE ANTIBODIES AND STREPTOKINASE RESISTANCE IN AN ABORIGINAL POPULATION IN NORTHERN AUSTRALIA.AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE. VOL. 26. ISSUE 1. P. 49-53 | 15 | 88% | 11 |
7 | TORRENS, I , OJALVO, AG , SERALENA, A , PUPO, E , LUGO, V , PAEZ, R , (1999) A MUTANT STREPTOKINASE LACKING THE C-TERMINAL 42 AMINO ACIDS IS LESS REACTIVE WITH PREEXISTING ANTIBODIES IN PATIENT SERA.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 266. ISSUE 1. P. 230 -236 | 18 | 67% | 2 |
8 | NIXON, G , BLATTNER, K , DAWSON, J , DOVEY, S , BLACK, MA , WILKINS, G , DUNN, AC , MCLELLAN, AD , (2011) STREPTOKINASE ANTIBODIES IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME IN THREE RURAL NEW ZEALAND POPULATIONS.JOURNAL OF CLINICAL PATHOLOGY. VOL. 64. ISSUE 5. P. 426 -429 | 12 | 71% | 1 |
9 | SINGH, S , DOSHI, S , SALAHUDDIN, S , TARIK, M , BARWAD, P , RAMAKRISHNAN, L , RAMAKRISHNAN, S , KARTHIKEYAN, G , BHARGAVA, B , BAHL, VK , (2015) ANTISTREPTOKINASE ANTIBODIES AND OUTCOME OF FIBRINOLYTIC THERAPY WITH STREPTOKINASE FOR LEFT-SIDED PROSTHETIC VALVE THROMBOSIS.AMERICAN HEART JOURNAL. VOL. 169. ISSUE 1. P. 170 -174 | 11 | 69% | 1 |
10 | CROSS, DB , WHITE, HD , (1994) ALLERGIC REACTIONS TO STREPTOKINASE - DOES ANTIBODY-FORMATION PREVENT REUSE IN A 2ND MYOCARDIAL-INFARCTION.CLINICAL IMMUNOTHERAPEUTICS. VOL. 2. ISSUE 6. P. 415-420 | 15 | 94% | 0 |
Classes with closest relation at Level 1 |